Reval appoints new director

Risk management software provider Reval has appointed Steve Rosenberg to its board of directors. Rosenberg is senior vice-president of Phase Forward, the data management provider for clinical trials and drug safety.

“Steve Rosenberg is a welcome addition to Reval’s board and we were fortunate to find someone with experience in hosting and supporting complex applications over the web,” says Jiro Okochi, Reval’s chief executive and co-founder.

Rosenberg has over 27 years’ experience in the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here